v3.26.1
Cover - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2025
Mar. 30, 2026
Jun. 30, 2025
Cover [Abstract]      
Document Type 10-K/A    
Document Annual Report true    
Document Period End Date Dec. 31, 2025    
Document Transition Report false    
Entity File Number 001-40973    
Entity Registrant Name AirSculpt Technologies, Inc.    
Entity Incorporation, State or Country Code DE    
Entity Tax Identification Number 87-1471855    
Entity Address, Address Line One 1111 Lincoln Road    
Entity Address, Address Line Two Suite 802    
Entity Address, City or Town Miami Beach    
Entity Address, State or Province FL    
Entity Address, Postal Zip Code 33139    
City Area Code 786    
Local Phone Number 709-9690    
Title of 12(b) Security Common Stock, par value $0.001 per share    
Trading Symbol AIRS    
Security Exchange Name NASDAQ    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers No    
Entity Current Reporting Status Yes    
Entity Interactive Data Current Yes    
Entity Filer Category Accelerated Filer    
Entity Small Business true    
Entity Emerging Growth Company true    
Entity Ex Transition Period true    
ICFR Auditor Attestation Flag false    
Document Financial Statement Error Correction [Flag] false    
Entity Shell Company false    
Entity Public Float     $ 79.8
Entity Common Stock, Shares Outstanding   70,545,681  
Documents Incorporated by Reference
None.
   
Entity Central Index Key 0001870940    
Current Fiscal Year End Date --12-31    
Document Fiscal Year Focus 2025    
Document Fiscal Period Focus FY    
Amendment Flag true    
Amendment Description AirSculpt Technologies, Inc. (the “Company”) is filing this Amendment No. 1 on Form 10-K/A (this “Amendment”) to its Annual Report on Form 10-K for the year ended December 31, 2025, originally filed with the Securities and Exchange Commission (the “SEC”) on March 31, 2026 (the “Original Filing”), to correct errors in the presentation of certain non-GAAP financial measures included in Part II, Item 7. “Management’s Discussion and Analysis of Financial Condition and Results of Operations” (“MD&A”) in the Original Filing.Specifically, the Company determined that a one-time non-cash adjustment related to the closure of its London facility was inaccurate in the calculation of Adjusted EBITDA, Adjusted EBITDA Margin, and Adjusted Net (Loss)/Income in the tables presented in the MD&A section of the Original Filing. This error resulted in an overstatement of Adjusted EBITDA and Adjusted Net (Loss)/Income of approximately $2.6 million, and an overstatement of Adjusted EBITDA Margin of approximately 1.7% for the year ended December 31, 2025. Additionally, there was an adjustment related to the tax effect of adjustments within the Adjusted Net (Loss)/Income which overstated Adjusted Net (Loss)/Income by $2.7 million, resulting in a $0.1 million net overstatement for the year ended December 31, 2025.The errors did not impact the Company’s consolidated financial statements, which were prepared in accordance with U.S. generally accepted accounting principles (“GAAP”) or the related audit opinion. The Company has corrected the presentation of these non-GAAP financial measures in this Amendment.This Amendment amends (i) the MD&A section of the Original Filing in its entirety and (ii) Part IV, Item 15. “Exhibits and Financial Statement Schedules” of the Original Filing to include, in accordance with Rule 12b-15 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), updated certifications from our Chief Executive Officer and Chief Financial Officer as required by Sections 302 and 906 of the Sarbanes-Oxley Act of 2002 as Exhibits 31.1, 31.2 and 32.1. In accordance with Rule 12b-15 under the Exchange Act, this Amendment amends and restates in their entirety each item identified in this paragraph. The Company has concluded that the non‑GAAP presentation errors giving rise to this amendment do not reflect the identification of any additional material weaknesses in internal control over financial reporting previously disclosed in Item 9A. “Controls and Procedures” of the Original Filing. Accordingly, this Amendment does not reflect the identification of any additional material weaknesses or changes to management’s prior conclusions regarding the effectiveness of the Company’s internal control over financial reporting.Except as described above, this Amendment does not modify, amend or update any other information, items or disclosures contained in the Original Filing, and all information, items or disclosures contained in this Amendment are as of the date of the Original Filing and do not reflect subsequent information or events beyond the date of the Original Filing. Accordingly, this Amendment should be read in conjunction with other filings made by the Company with the SEC subsequent to the filing of the Original Filing, including any amendments to those filings. Capitalized terms used but not defined herein shall have the meanings ascribed to such terms in the Original Filing.